CLINICAL_TRIALS trial_result · 2014-01-07

Clinical Trial Update: FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer [Phase 2]

Phase 2 clinical trial evaluating FACBC PET/CT for diagnosing primary prostate cancer was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: David M. Schuster, MD | Conditions: Prostate Cancers | Phase 2 | Status: TERMINATED | Results posted: 2014-01-07